Management of Atrial Fibrillation in Heart Failure

Rationale for Beta-Blocker Superiority

• The European Society of Cardiology recommends beta-blockers as the primary rate control agent in patients with atrial fibrillation and heart failure with reduced ejection fraction, as they provide mortality benefit, which digoxin does not offer 4
• Beta-blockers achieved rate control targets in 70% of patients compared to 54% with calcium channel blockers, demonstrating superior efficacy in the AFFIRM study 5, 6
• Beta-blockers are more effective than digoxin for controlling ventricular rate during exercise, which is critical for active patients 5, 7
• The American Heart Association recommends beta-blockers be initiated cautiously but are recommended in patients with AF and heart failure with reduced ejection fraction 5, 6

Appropriate Use of Digoxin in This Clinical Scenario

• The European Heart Society suggests digoxin may be used in addition to, or prior to, a beta-blocker in patients with AF and LVEF <40% 1, 2, 3
• In the longer term, a beta-blocker, either alone or in combination with digoxin, is the preferred treatment for rate control in patients with LVEF <40% 1, 2, 3
• Consider adding digoxin when rate control cannot be adequately controlled with beta-blocker alone, both at rest and during exercise 8

Digoxin Dosing in Heart Failure

• The starting dose of digoxin is 0.25 mg daily in adults with normal renal function 1, 2, 3
• A reduced dose of 0.125 or 0.0625 mg daily should be used in elderly patients and those with renal impairment 1, 2, 3
• The target therapeutic serum concentration of digoxin is 0.6 to 1.2 ng/mL, lower than previously recommended 3

Critical Safety Considerations

• The American College of Cardiology recommends initiating beta-blockers cautiously in patients with AF and heart failure with reduced ejection fraction, starting at low doses and titrating slowly 5, 6
• Digoxin can cause atrial and ventricular arrhythmias, particularly with hypokalemia 1, 2, 3
• Certain drugs increase plasma digoxin levels: amiodarone, diltiazem, verapamil, certain antibiotics, and quinidine 3
• Signs of digoxin toxicity include: confusion, nausea, anorexia, visual disturbances, and cardiac arrhythmias 3